While Christian W. Jansson has taken the position as acting CEO in Enzymatica, he has consequently stepped down as Chairman of the Board. Board member Fredrik Lindberg has been appointed new Chairman of Enzymatica.
Fredrik Lindberg, member of Enzymatica’s Board since 2012, is the Chief Scientific Officer and co-founder of Bone Support AB. Fredrik is a Doctor of Medicine (Ph.D), and has extensive experience in the medical device industry and growth companies with international operations.
For more information, please contact:
Christian W. Jansson, acting CEO Enzymatica AB
Phone: +46 706 37 12 58. E-mail: email@example.com
Tina Dackemark Lawesson, Senior Communications Officer Enzymatica AB
Phone: +46 286 31 00. E-mail: firstname.lastname@example.org
About Enzymatica AB (publ)
Enzymatica AB (publ) develops and sells medical technology products based on an enzyme from deep-sea cod. Our development includes medical devices in upper respiratory infections and oral health, and veterinary products in oral health and dermatology. The launched medical portfolio includes ColdZyme® against common colds. It is headquartered in Lund, Sweden, and is listed on Aktietorget. For more information, please visit www.enzymatica.com.